- Rilpivirine, sold
under the
brand names Edurant and Rekambys, is a medication,
developed by Tibotec, used for the
treatment of HIV/AIDS. It is a second-generation...
-
Archived from the
original on 28
February 2014.
Retrieved 23
February 2014. "
Edurant-
rilpivirine hydrochloride tablet, film coated". DailyMed. 8 June 2020...
-
Remicade Simponi Simponi Aria
Stelara Tremfya Infectious diseases therapies Edurant Intelence Prezcobix Prezista Symtuza Janssen COVID-19
vaccine Neuroscience...
-
Archived from the
original on 15 June 2021.
Retrieved 12 June 2021. "
Edurant-
rilpivirine hydrochloride tablet, film coated". DailyMed.
Archived from...
-
Innovative medicine Balversa Concerta Darzalex Ditropan Duragesic Edurant Elmiron Erleada Haldol Imbruvica Intelence Invega Invokamet Invokana Prezcobix...
- Intelence, and was
approved by the FDA in 2008.
Rilpivirine has the
trade name
Edurant, and was
approved by the FDA in May 2011.
Doravirine has the
trade name...
-
Treatment Options in Allergy. 2 (2): 110–123. doi:10.1007/s40521-015-0046-0. "
Edurant" (PDF).
Janssen Products.
Archived from the
original (PDF) on 23 April...
-
edratide (USAN)
edrecolomab (INN)
edrophonium chloride (INN)
Edrophonium Edurant efalizumab (USAN)
efaproxiral (USAN)
efaroxan (INN)
efavirenz (INN) efbemalenograstim...
-
diarylquinoline anti-tuberculosis drug
Rilpivirine (TMC278,
tradename Edurant), an
NNRTI Simeprevir (TMC435,
tradename Olysio), an HCV NS3/4A protease...
-
approved by the FDA for HIV
therapy in May 2011
under the
brand name
Edurant.
Edurant is
approved for treatment-naive
patients with a
viral load of 100,000...
